PathMaker Neurosystems is a clinical-stage bioelectronic medicine company developing breakthrough non-invasive systems for the treatment of patients with muscle spasticity, paralysis and weakness. With offices in Boston and Paris and a veteran team in place, we are collaborating with world-class research institutions to rapidly bring to market disruptive products for treating chronic neuromotor conditions.
PathMaker’s flagship product, MyoAmplifierTM, is an advanced non-invasive platform that represents the first technology that can treat paralysis and muscle weakness in children and adults with damage to neuromotor pathways from conditions including cerebral palsy, stroke, spinal cord injury and other conditions. MyoAmplifier is based on PathMaker’s proprietary TripleStimTM that provides simultaneous activation of motor cortex, spinal cord and peripheral nerve serving targeted muscles to dramatically improve motor function in patients with paralysis/weakness.
- Client Nader Yaghoubi, MD
- Date December 20, 2017
- Tags Pre-Seed
- URL View Project